Cargando…
May Mangafodipir or Other SOD Mimetics Contribute to Better Care in COVID-19 Patients?
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is characterized by massive inflammation of the arterial endothelium accompanied by vasoconstriction and widespread pulmonary micro thrombi. As a result, due to the destruction of nitric oxide ((•)NO) by inflammatory superoxide (O(2)(•−)),...
Autores principales: | Karlsson, Jan Olof G, Jynge, Per, Ignarro, Louis J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601469/ https://www.ncbi.nlm.nih.gov/pubmed/33050459 http://dx.doi.org/10.3390/antiox9100971 |
Ejemplares similares
-
Mangafodipir a Selective Cytoprotectant — with Special Reference to Oxaliplatin and Its Association to Chemotherapy-Induced Peripheral Neuropathy (CIPN)()()
por: Karlsson, Jan Olof G., et al.
Publicado: (2017) -
The Damaging Outcome of the POLAR Phase III Trials Was Due to Avoidable Time-Dependent Redox Interaction between Oxaliplatin and PledOx
por: Karlsson, Jan Olof G., et al.
Publicado: (2021) -
Exacerbated Neuropathy in POLAR A and M Trials Due to Redox Interaction of PledOx-Associated Mn(2+) and Oxaliplatin-Associated Pt(2+)
por: Karlsson, Jan Olof G., et al.
Publicado: (2023) -
Letter in response to: “Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N acetylcysteine for paracetamol overdose—the PP100-01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial”
por: Karlsson, Jan Olof G., et al.
Publicado: (2019) -
Gastrointestinal AEs seen in the POP trial due to SOD mimetic activity of calmangafodipir?
por: Karlsson, Jan Olof G.
Publicado: (2019)